HealthtechDigital healthBio Tech/Life SciencesB2BB2B2C1-5 employees
Serial Entrepreneur
Immigrant FounderAbout
T-NeuroDx is developing a blood-based diagnostic test to detect Alzheimer's disease earlier by measuring hiT Cells - a novel biomarker that causes Alzheimer's-like pathology. The company aims to predict disease progression before cognitive symptoms appear, addressing the critical gap where current biomarkers only measure pathology, not who will develop the disease.
Traction & Metrics
Financial
$0
ARR
Fundraising
$700K
Previous Round
